Swiss pharmaceutical giant Roche announced a significant investment of $50 billion in the United States over the next five years, with plans to create 12,000 new jobs. The company will focus on high-tech research and development sites and new manufacturing facilities in California, Indiana, Massachusetts, and Pennsylvania.
The announcement comes as US President Donald Trump has urged foreign businesses to invest more in the country. Roche’s investment is seen as a response to Trump’s sweeping tariffs earlier this month, which aimed to reduce the large US trade deficit with Switzerland.
Roche currently employs 25,000 people in the US and operates 15 research centers and 13 manufacturing sites across eight states. The new investments will add 1,000 jobs at Roche in the US and more than 11,000 in support of new US manufacturing capabilities.
The company has deep ties to the US market and said it currently generates nearly $25 billion in sales in its key pharmaceuticals division alone. Roche’s share price has fallen by about 18% over the past month, largely due to the impact of the US tariff announcement on April 2.
Source: https://apnews.com/article/roche-switzerland-pharmaceuticals-us-trump-kellersutter-f765bcfc4b65d5e1d213d3a01d079ae8